Nanoleq, a Swiss wearable technology company, successfully completed a CHF 11.5M Series A funding round to advance its innovative smart textile solutions for health monitoring.
Target Information
Nanoleq is a Swiss company specializing in wearable technology, headquartered in Zurich. Founded in 2017 by a team of four biomedical engineers, Nanoleq initially focused on supplying innovations in smart textiles. The company has made significant strides in developing and commercializing advanced materials, including stretchable cables and dry electrodes that are not only comfortable and washable but also streamline the manufacturing process.
With a current workforce of 24 employees, Nanoleq plans to expand further by establishing a location in Berlin in 2022 for its marketing, design, and software development teams. The company's innovations serve as a foundation for various applications in e-textiles, particularly in areas such as vital sign monitoring and electrical stimulation. In the near future, Nanoleq is set to launch its own pioneering wearable product that will enhance users' connection to their bodies through interactive exercises and live biofeedback, marking a notable advance in the burgeoning field of smart textiles.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The smart textile industry is rapidly evolving, driven by advancements in technology and an increasing consumer demand for innovative health monitoring solutions. This sector is particularly relevant in countries like Switzerland, where a strong emphas
Similar Deals
Sofinnova Partners and Earlybird Venture Capital → HAYA Therapeutics SA
2025
Capnamic Ventures
invested in
Nanoleq
in 2021
in a Series A deal
Disclosed details
Transaction Size: $13M